Search
for

    Research

    5 / 1000+ results

    Learn

    9 / 66 results

    Community Join

    5 / 1000+ results

      community New Hair Loss Cure: AMP-303 Is Back. It’s what PP405 should have been.

       7 upvotes 5 months ago
      AMP-303 and AMP-601 are new hair loss treatments targeting dermal papilla cells, with AMP-303 showing early efficacy in transitioning vellus hairs to terminal hairs after one injection. Further clinical trials are planned, and these treatments are seen as promising due to their biologic approach and less frequent application compared to daily treatments.

      community South Korea is debating whether hair loss should be covered by public healthcare. That alone says a lot about how we still misunderstand hair loss.

       67 upvotes 8 months ago
      South Korea is debating whether hair loss treatments should be covered by public healthcare, highlighting the issue's impact on mental health and social functioning. The discussion centers on whether hair loss should be classified as a medical condition rather than a cosmetic issue, considering its psychological effects and the biological processes involved.

      community Why hasn’t anyone made a "DHT sponge" biologic yet???

      in Research/Science  45 upvotes 10 months ago
      The conversation discusses the potential for developing a biologic "DHT sponge" to neutralize DHT in the bloodstream as a treatment for hair loss, suggesting it could be more targeted and have fewer side effects than current treatments like finasteride and dutasteride. Concerns include the complexity, cost, and potential side effects of such a treatment, as well as skepticism about its feasibility and market interest.

      community Hair loss transformation 14-18 yrs old

       3 upvotes 1 month ago
      The user shared their hair loss transformation and treatment routine, which includes dutasteride, finasteride, various forms of minoxidil, and other topical treatments. They emphasized consistency in their regimen and offered to answer questions about their experience.